<span>Our approach to changes in EU IVDR regulation</span>
December 1, 2022

Our approach to changes in EU IVDR regulation

Effective May 26, 2022, the European Union (EU) In Vitro Diagnostics Regulation (IVDR) replaced the In Vitro Diagnostics Directive. This regulation governs how in vitro diagnostics (IVDs) and lab-developed tests (LDTs) are regulated for diagnostic and EU/European Economic Area patient management purposes.
<span>Real-world evidence and Phase IV solutions</span>
December 7, 2022

Real-world evidence and Phase IV solutions

Generating product value is key to market success. Real-world data (RWD) are the basis to generate the right evidence for your value story-aiming to address the needs of various stakeholders like insurance companies, governmental bodies, medical associations and patient advocacy groups.
<span>Reimagining site activation with ready to enroll (RTE) goals</span>
January 6, 2023

Reimagining site activation with ready to enroll (RTE) goals

Preparing investigator sites for RTE requires agility, efficient processes, creative problem-solving and regional expertise across multiple geographic areas. For each study, we assign a team of Labcorp startup operations specialists responsible for site activations within each proposed country.